PriceTargets.com logo

Miromatrix Medical - MIRO Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $3.00
  • Forecasted Upside: -11.50%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.39 As of 12/13/2023 01:00 AM ET
+0 (0.00%)
Get New Miromatrix Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MIRO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MIRO

Analyst Price Target is $3.00
▼ -11.50% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Miromatrix Medical in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a -11.50% upside from the last price of $3.39.

This chart shows the closing price for MIRO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Miromatrix Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/12/2023Piper SandlerLower Target$6.00 ➝ $3.00Low
4/3/2023Piper SandlerLower TargetOverweight$9.00 ➝ $6.00Low
11/14/2022Piper SandlerBoost TargetOverweight$8.00 ➝ $9.00Low
8/31/2022Piper SandlerInitiated CoverageOverweight$8.00Low
7/19/2021Craig HallumInitiated CoverageBuy$22.00High
(Data available from 4/24/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Miromatrix Medical logo
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $3.39
Low: $3.39
High: $3.39

50 Day Range

MA: $3.38
Low: $3.31
High: $3.40

52 Week Range

Now: $3.39
Low: $0.91
High: $4.35

Volume

N/A

Average Volume

80,095 shs

Market Capitalization

$92.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.01

Frequently Asked Questions

What sell-side analysts currently cover shares of Miromatrix Medical?

The following Wall Street research analysts have issued stock ratings on Miromatrix Medical in the last year: Piper Sandler.
View the latest analyst ratings for MIRO.

What is the current price target for Miromatrix Medical?

1 Wall Street analysts have set twelve-month price targets for Miromatrix Medical in the last year. Their average twelve-month price target is $3.00, suggesting a possible downside of 11.5%. Piper Sandler has the highest price target set, predicting MIRO will reach $3.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $3.00 for Miromatrix Medical in the next year.
View the latest price targets for MIRO.

What is the current consensus analyst rating for Miromatrix Medical?

Miromatrix Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MIRO.

What other companies compete with Miromatrix Medical?

Other companies that are similar to Miromatrix Medical include Neon Therapeutics, Entasis Therapeutics, Kinnate Biopharma, NGM Biopharmaceuticals and LianBio. Learn More about companies similar to Miromatrix Medical.

How do I contact Miromatrix Medical's investor relations team?

The company's listed phone number is 952-942-6000 and its investor relations email address is [email protected]. The official website for Miromatrix Medical is www.miromatrix.com. Learn More about contacing Miromatrix Medical investor relations.